Russell Investments Group Ltd. increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 46.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 461,284 shares of the company's stock after purchasing an additional 146,275 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.10% of GE HealthCare Technologies worth $36,076,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of GEHC. CoreFirst Bank & Trust bought a new position in shares of GE HealthCare Technologies in the fourth quarter worth about $25,000. Continuum Advisory LLC raised its holdings in GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company's stock worth $31,000 after purchasing an additional 168 shares during the period. Runnymede Capital Advisors Inc. bought a new position in GE HealthCare Technologies during the fourth quarter worth about $28,000. Bank of Jackson Hole Trust bought a new position in shares of GE HealthCare Technologies during the 4th quarter valued at about $32,000. Finally, Flagship Wealth Advisors LLC acquired a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $34,000. Institutional investors own 82.06% of the company's stock.
Analyst Ratings Changes
A number of equities analysts have weighed in on GEHC shares. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a report on Friday, February 14th. The Goldman Sachs Group upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and increased their target price for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Finally, Citigroup lifted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, February 13th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $97.73.
Check Out Our Latest Research Report on GEHC
GE HealthCare Technologies Price Performance
Shares of NASDAQ:GEHC traded up $0.53 during midday trading on Friday, hitting $62.81. The stock had a trading volume of 7,219,909 shares, compared to its average volume of 3,127,495. The company's 50-day moving average price is $81.75 and its 200-day moving average price is $84.00. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $28.72 billion, a P/E ratio of 14.51, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. As a group, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.
GE HealthCare Technologies Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.22%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.23%.
GE HealthCare Technologies Profile
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
See Also
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
